Paras Genetech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -32.00%
- Profit Growth -82.20%
- Ebitda -340.89%
- Net Worth 0.70%
- Total Assets -31.38%
About Paras Genetech
Paras Genetech Private Limited (PGPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 December 2007 and has a history of 17 years and one month. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shreyankumar Nareshbhai and Reena Shreyan serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01111GJ2007PTC052367
-
Company No.
052367
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Dec 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Paras Genetech Private Limited offer?
Paras Genetech Private Limited offers a wide range of products and services, including Seeds and Plant Saplings, Fruit Seeds, Bean Seeds, Hybrid Seeds, Hybrid Cotton Seed, Seeds, Cotton Seeds, Moong Seeds, Hybrid Watermelon Seeds, Grain Seed.
Who are the key members and board of directors at Paras Genetech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shreyankumar Nareshbhai
|
Director | 17-Dec-2007 | Current |
|
Reena Shreyan
|
Director | 17-Dec-2007 | Current |
Financial Performance of Paras Genetech.
Paras Genetech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 32% decrease. The company also saw a substantial fall in profitability, with a 82.2% decrease in profit. The company's net worth moved up by a moderate rise of 0.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paras Genetech?
In 2018, Paras Genetech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Paras Genetech?
Unlock and access historical data on people associated with Paras Genetech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paras Genetech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paras Genetech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
